S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
Algeria's government pushes staples to subsidized markets to stave off Ramadan shortages
How major US stock indexes fared Thursday, 3/28/2024
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
Algeria's government pushes staples to subsidized markets to stave off Ramadan shortages
How major US stock indexes fared Thursday, 3/28/2024
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
Algeria's government pushes staples to subsidized markets to stave off Ramadan shortages
How major US stock indexes fared Thursday, 3/28/2024
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
Algeria's government pushes staples to subsidized markets to stave off Ramadan shortages
How major US stock indexes fared Thursday, 3/28/2024
ETR:SHL

Siemens Healthineers (SHL) Stock Price, News & Analysis

€56.72
+0.34 (+0.60%)
(As of 03/28/2024 ET)
Today's Range
€56.28
€56.94
50-Day Range
€51.06
€57.70
52-Week Range
€44.39
€58.14
Volume
814,605 shs
Average Volume
N/A
Market Capitalization
$63.53 billion
P/E Ratio
42.01
Dividend Yield
1.67%
Price Target
€63.00

Siemens Healthineers MarketRank™ Stock Analysis

Analyst Rating
0.00 Rating Score
Upside/​Downside
11.1% Upside
€63.00 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.35 out of 5 stars

SHL stock logo

About Siemens Healthineers Stock (ETR:SHL)

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, solutions, and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services, and digital solutions and applications for managing treatment and therapy. Its Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms. It offers essential technical customer service, such as maintenance and repair; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as digital healthhcare consulting, products, and services. The company is headquartered in Forchheim, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.

SHL Stock Price History

SHL Stock News Headlines

BoE expected to follow Fed with unchanged rates
Siemens Healthineers: Strong Return, Still A 'Buy'
4x Better than Bitcoin
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
Siemens Healthineers Share Price (1SHL.MI)
4x Better than Bitcoin
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
Siemens Healthineers 4Q Net Pft EUR636M
See More Headlines
Receive SHL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Siemens Healthineers and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
71,400
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
€60.24
High Stock Price Target
€67.20
Low Stock Price Target
€49.00
Potential Upside/Downside
+6.8%
Consensus Rating
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$1.52 billion
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$21.78 billion
Cash Flow
€1.45 per share
Book Value
€16.14 per share

Miscellaneous

Outstanding Shares
1,120,000,000
Free Float
N/A
Market Cap
$63.15 billion
Optionable
Not Optionable
Beta
0.73
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Dr. Bernhard Montag (Age 55)
    President, CEO & Chairman of Management Board
    Comp: $3.15M
  • Dr. Jochen Schmitz Ph.D. (Age 58)
    CFO & Member of Management Board
    Comp: $1.86M
  • Ms. Darleen Caron (Age 60)
    Chief Human Resources Officer, Labor Director & Member of Management Board
    Comp: $1.66M
  • Ms. Elisabeth Staudinger-Leibrecht (Age 54)
    Member of Management Board
    Comp: $1.15M
  • Mr. Marc Koebernick
    Head of Investor Relations
  • Christian Klaussner
    Executive Vice President of Finance
  • Andre Hartung
    Head of Imaging
  • Carsten Bertram
    Head of Advanced Therapies
  • Mr. David C. Pacitti (Age 58)
    Head of Americas
  • Ms. Sharon J. Bracken (Age 53)
    Head of Diagnostics

Should I Buy Siemens Healthineers Stock? SHL Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Siemens Healthineers AG:

  • Siemens Healthineers appoints Vivek Kanade as new Head for its Middle East and Africa operations, indicating strong leadership and potential growth in those regions.
  • The Egyptian Minister of Health and Population reviewing Siemens Healthineers groundbreaking innovations at Arab Health showcases the company's commitment to innovation and potential market expansion.
  • Recent developments in groundbreaking innovations by Siemens Healthineers could lead to increased market share and revenue growth.
  • Positive market sentiment towards Siemens Healthineers AG may drive the stock price higher, potentially benefiting investors.
  • Strategic partnerships and collaborations by Siemens Healthineers could open up new opportunities for revenue generation and market expansion.

Cons

Investors should be bearish about investing in Siemens Healthineers AG for these reasons:

  • Market competition in the healthcare technology sector could pose challenges for Siemens Healthineers AG's market position and profitability.
  • Regulatory changes or challenges in key markets could impact the company's operations and financial performance negatively.
  • Economic uncertainties or global events may affect the demand for healthcare technology products and services, impacting Siemens Healthineers AG's revenue streams.
  • Fluctuations in currency exchange rates could impact the company's international operations and financial results.
  • Technological disruptions or advancements by competitors could threaten Siemens Healthineers AG's market share and competitive edge.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, March 25, 2024. Please send any questions or comments about these Siemens Healthineers pros and cons to contact@marketbeat.com.

SHL Stock Analysis - Frequently Asked Questions

What is Siemens Healthineers' stock price target for 2024?

0 analysts have issued twelve-month price targets for Siemens Healthineers' shares. Their SHL share price targets range from €63.00 to €63.00. On average, they anticipate the company's stock price to reach €63.00 in the next twelve months. This suggests a possible upside of 11.1% from the stock's current price.
View analysts price targets for SHL
or view top-rated stocks among Wall Street analysts.

How have SHL shares performed in 2024?

Siemens Healthineers' stock was trading at €52.60 at the beginning of 2024. Since then, SHL stock has increased by 7.8% and is now trading at €56.72.
View the best growth stocks for 2024 here
.

Is Siemens Healthineers a good dividend stock?

Siemens Healthineers (ETR:SHL) pays an annual dividend of €0.95 per share and currently has a dividend yield of 1.73%. The dividend payout ratio is 70.37%. This payout ratio is at a healthy, sustainable level, below 75%.

What other stocks do shareholders of Siemens Healthineers own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Siemens Healthineers investors own include QUALCOMM (QCOM), Illumina (ILMN), Regeneron Pharmaceuticals (REGN), Broadcom (AVGO), Gilead Sciences (GILD), Moderna (MRNA), Vertex Pharmaceuticals (VRTX), Adobe (ADBE) and Applied Materials (AMAT).

This page (ETR:SHL) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners